NCT04956445View on ClinicalTrials.gov

Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development

RecruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

March 17, 2020

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Covid19

Trial Locations (2)

70112

RECRUITING

Tulane University Medical Center, New Orleans

RECRUITING

University Medical Center New Orleans, New Orleans

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Centers for Disease Control and Prevention

FED

collaborator

Gilead Sciences

INDUSTRY

lead

Tulane University

OTHER

NCT04956445 - Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development | Biotech Hunter | Biotech Hunter